Sarepta Therapeutics | SRPT - القيمة السوقية

سعر السهم
20.30
التغيير اليومي
-0.12 -0.59%
شهريا
-14.60%
سنويا
-66.41%
Q2 التوقعات
19.87




القيمة السوقية تغيير تاريخ
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 19.39B 2.83B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12